{
    "nctId": "NCT01000155",
    "title": "A Phase II Pharmacodynamic Investigation of the Efficacy of Vorinostat to Induce Fetal Hemoglobin in Adults With Severe Sickle Cell Disease Who Have Not Benefitted From Prior Therapy",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "and",
                "operands": [
                    {
                        "type": "variable",
                        "value": "Diagnosis of sickle cell disease"
                    },
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "At least 1 painful episode per year averaged over the previous 3 years"
                            },
                            {
                                "type": "variable",
                                "value": "History of priapism"
                            },
                            {
                                "type": "variable",
                                "value": "History of stroke"
                            },
                            {
                                "type": "variable",
                                "value": "History of acute chest syndrome"
                            },
                            {
                                "type": "variable",
                                "value": "History of avascular necrosis"
                            },
                            {
                                "type": "variable",
                                "value": "History of multi-organ failure"
                            },
                            {
                                "type": "variable",
                                "value": "Need for chronic narcotic medications for pain from sickle cell disease"
                            }
                        ]
                    },
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Failed a previous attempt at treatment with hydroxyurea"
                            },
                            {
                                "type": "variable",
                                "value": "Inability to tolerate hydroxyurea treatment due to severe side effects"
                            },
                            {
                                "type": "variable",
                                "value": "Contraindications to hydroxyurea"
                            }
                        ]
                    },
                    {
                        "type": "variable",
                        "value": "18 years of age or older"
                    },
                    {
                        "type": "variable",
                        "value": "Hematologic laboratory values as outlined in the protocol"
                    },
                    {
                        "type": "variable",
                        "value": "Non-hematologic laboratory values as outlined in the protocol"
                    },
                    {
                        "type": "variable",
                        "value": "Must agree not to donate blood or other bodily fluid while taking the study drug and for 28 days thereafter"
                    },
                    {
                        "type": "variable",
                        "value": "Women of child-bearing potential (WCBP) must have a negative serum pregnancy test 72 hours or less prior to starting treatment"
                    },
                    {
                        "type": "variable",
                        "value": "Women of child-bearing potential and men must agree to use 2 forms of adequate contraception prior to study entry and for the duration of study participation"
                    },
                    {
                        "type": "variable",
                        "value": "Must have minimum age of 18 Years"
                    }
                ]
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Subjects with hemoglobin SC or SB+ thalassemia"
                            },
                            {
                                "type": "variable",
                                "value": "Subjects on chronic transfusion program"
                            },
                            {
                                "type": "variable",
                                "value": "Subjects who have received RBC transfusions cannot have >15% adult hemoglobin"
                            },
                            {
                                "type": "variable",
                                "value": "Known positive status for HIV, active hepatitis B or hepatitis C"
                            },
                            {
                                "type": "variable",
                                "value": "Pregnant or breast feeding women"
                            },
                            {
                                "type": "and",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "History of malignancy"
                                    },
                                    {
                                        "type": "not",
                                        "operands": [
                                            {
                                                "type": "or",
                                                "operands": [
                                                    {
                                                        "type": "variable",
                                                        "value": "Historically disease-free for at least 5 years"
                                                    },
                                                    {
                                                        "type": "variable",
                                                        "value": "Deemed by the investigator to be at low risk for recurrence of malignancy"
                                                    },
                                                    {
                                                        "type": "variable",
                                                        "value": "Diagnosed and adequately treated within the past 5 years"
                                                    }
                                                ]
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "type": "variable",
                                "value": "Subjects with a history of thrombosis or other reason (other than sickle cell disease) for enhanced thrombotic risk"
                            },
                            {
                                "type": "variable",
                                "value": "Subjects with unresolved infections"
                            },
                            {
                                "type": "variable",
                                "value": "Severe or uncontrolled medical conditions that could compromise study participation"
                            },
                            {
                                "type": "variable",
                                "value": "Subjects on fetal hemoglobin inducing agents"
                            },
                            {
                                "type": "variable",
                                "value": "Subjects on any other experimental treatment within 90 days of the first dose of study drug or who have not recovered from the side effects of such therapy"
                            },
                            {
                                "type": "variable",
                                "value": "Known allergic reaction to a histone deacetylase inhibitor"
                            },
                            {
                                "type": "variable",
                                "value": "Subjects who have received valproic acid for treatment of epilepsy within 30 days of enrollment"
                            },
                            {
                                "type": "variable",
                                "value": "Subjects who have received any HDAC inhibitors other than valproic acid"
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol('18 years of age or older'), Symbol('Diagnosis of sickle cell disease'), Symbol('Hematologic laboratory values as outlined in the protocol'), Symbol('Must agree not to donate blood or other bodily fluid while taking the study drug and for 28 days thereafter'), Symbol('Must have minimum age of 18 Years'), Symbol('Non-hematologic laboratory values as outlined in the protocol'), Symbol('Women of child-bearing potential (WCBP) must have a negative serum pregnancy test 72 hours or less prior to starting treatment'), Symbol('Women of child-bearing potential and men must agree to use 2 forms of adequate contraception prior to study entry and for the duration of study participation'), Or(Symbol('Contraindications to hydroxyurea'), Symbol('Failed a previous attempt at treatment with hydroxyurea'), Symbol('Inability to tolerate hydroxyurea treatment due to severe side effects')), Or(Symbol('At least 1 painful episode per year averaged over the previous 3 years'), Symbol('History of acute chest syndrome'), Symbol('History of avascular necrosis'), Symbol('History of multi-organ failure'), Symbol('History of priapism'), Symbol('History of stroke'), Symbol('Need for chronic narcotic medications for pain from sickle cell disease')), Not(Or(Symbol('Known allergic reaction to a histone deacetylase inhibitor'), Symbol('Known positive status for HIV, active hepatitis B or hepatitis C'), Symbol('Pregnant or breast feeding women'), Symbol('Severe or uncontrolled medical conditions that could compromise study participation'), Symbol('Subjects on any other experimental treatment within 90 days of the first dose of study drug or who have not recovered from the side effects of such therapy'), Symbol('Subjects on chronic transfusion program'), Symbol('Subjects on fetal hemoglobin inducing agents'), Symbol('Subjects who have received RBC transfusions cannot have >15% adult hemoglobin'), Symbol('Subjects who have received any HDAC inhibitors other than valproic acid'), Symbol('Subjects who have received valproic acid for treatment of epilepsy within 30 days of enrollment'), Symbol('Subjects with a history of thrombosis or other reason (other than sickle cell disease) for enhanced thrombotic risk'), Symbol('Subjects with hemoglobin SC or SB+ thalassemia'), Symbol('Subjects with unresolved infections'), And(Symbol('History of malignancy'), Not(Or(Symbol('Deemed by the investigator to be at low risk for recurrence of malignancy'), Symbol('Diagnosed and adequately treated within the past 5 years'), Symbol('Historically disease-free for at least 5 years')))))))"
}